Complement Profiling in Glomerular Disease: Insights from Laser Microdissection and Mass Spectrometry

Sanjeev Sethi1

  • 1Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.

Insights

Laser microdissection and mass spectrometry (LMD/MS) offers detailed complement analysis in kidney biopsies. This advanced method aids in understanding glomerular diseases and personalizing anticomplement therapy.

Area of Science:

  • Nephrology
  • Immunology
  • Proteomics

Background:

  • Complement activation is common in glomerular diseases, indicated by C3c and C1q deposition on biopsies.
  • Kidney biopsies offer limited insights, failing to identify all complement proteins or distinguish active from inactive forms.

Purpose of the Study:

  • To evaluate the utility of laser microdissection and mass spectrometry (LMD/MS) for comprehensive complement profiling in glomerular diseases.
  • To analyze the proteomic complement profile in various glomerular diseases using LMD/MS.

Main Methods:

  • Utilized laser microdissection and mass spectrometry (LMD/MS) for in-depth proteomic evaluation of kidney biopsy samples.
  • Applied principal component analysis, volcano plots, and heatmaps for protein analysis.

Main Results:

  • LMD/MS identified distinct complement profiles and pathways across different glomerular diseases, including membranous nephropathy, Ig-associated GN, C3 glomerulopathy, and IgA nephropathy.
  • Demonstrated variations in complement burden and profile even within specific diseases, such as different antigens in membranous nephropathy.
  • Showcased LMD/MS's ability to determine the presence of active complement fragments and quantify complement burden.

Conclusions:

  • LMD/MS is a valuable tool for detailed analysis of complement proteins, regulatory proteins, and pathways in glomerular diseases.
  • Accurate complement profiling using LMD/MS is crucial for personalized treatment strategies, especially with the advent of new anticomplement drugs.